Article |

Subcutaneous and Intranasal Administration of RA 27/3 Rubella Vaccine:  Alone and in Conjunction With Live Attenuated Measles Vaccine

Simin Saidi, VMD, MPH; Kiarash Naficy, MD
Am J Dis Child. 1969;118(2):209-212. doi:10.1001/archpedi.1969.02100040211009.
Text Size: A A A
Published online

THE RA 27/3 strain of rubella vaccine isolated from a tissue explant of fetal kidney derived from conceptus of a rubellainfected mother and attenuated after several passages in WI-38 human fibroblast tissue culture has been shown in several clinical trials to be effective for induction of sero-immunity when administered subcutaneously as well as intranasally, with no transmission to sero-negative contacts.1-3 To the best of our knowledge, RA 27/3 has not been used simultaneously with other vaccines. This communication presents our findings on subcutaneous and intranasal administration of RA 27/3 rubella vaccine, alone and in conjunction with live attenuated measles vaccine.

Materials and Methods  Vaccine.—The RA 27/3 rubella vaccine (batch AR/2/2A) was obtained with 102.8 TCID50 titer by monkey kidney interference method. Measles vaccine (Schwarz strain) in 20 dose vials with the titer of 102.8 TCID50 in chick embryo fibroblast was used.Antigens.—Measles and


Sign In to Access Full Content

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

Purchase Online Access to this article for 24 hours

First Page Preview

View Large
First page PDF preview





Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).
Submit a Comment


Some tools below are only available to our subscribers or users with an online account.

Sign In to Access Full Content

Related Content

Customize your page view by dragging & repositioning the boxes below.